Volume 2, Issue 12
Correction of lipid and purine metabolism in patients with arterial hypertension, obesity and gout
Author: Maryana Vatseba
Abstract: Our study aimed to evaluate the methods of correction of lipid and purine metabolism in patients with hypertension combined with obesity and gout. The study involved 46 patients with hypertension, gout and obesity. The aim of research was to improve treatment of patients with hypertension, gout and obesity by using Losartan and Meldonium. Application to the basic therapy Losartan and Meldonium improves lipid profile and reduces the level of uric acid. Thus, the combined use of Losartan and Meldonium is feasible, effective and safe for prolonged use.
Download Full Article: Click Here
Support Us
If you are interested in supporting our work and would like to contribute, you are welcome to mail me at jpbr.anil@gmail.com or at info@thepharmajournal.com it will be a great help and will surely be appreciated.
